Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2018  |  Volume : 50  |  Issue : 6  |  Page : 320--325

Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study

Sereen Rose Thomson1, Bharti Chogtu1, Ranjan Shetty2, Tom Devasia3 
1 Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
2 Department of Cardiology, Manipal Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
3 Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India

Correspondence Address:
Dr. Bharti Chogtu
Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal,
India

INTRODUCTION: Randomized controlled trials, observational studies, and meta-analysis suggest risk of hyperglycemia in patients on statins, and this association is being viewed with renewed interest globally. The present study has tried to explore the possible diabetogenic effect of statins, the mechanism of this effect, and various comorbidities associated with this causation. MATERIALS AND METHODS: This cross-sectional study was carried out at the Department of Cardiology from October 2015 to March 2017. Patients on statins for at least 1 year and normoglycemic at the time of statin initiation were recruited in the study. The outcome of the present study was development of new-onset diabetes mellitus (NODM). Blood glucose levels and insulin levels were estimated. Other adverse reactions of statins and associated comorbidities in the patients were recorded. Descriptive statistics were used to analyze adverse drug reactions. RESULTS: A total of 104 patients met the inclusion criteria, of which eight patients (7.7%) developed NODM and 4 (3.8%) developed prediabetes. Atorvastatin 40 mg was most commonly prescribed statin. About 25% of patients taking atorvastatin 80 mg developed diabetes CONCLUSION: Statins have a mild-to-moderate risk of developing NODM. The dose of statins is an important factor that increases the risk of diabetes in statin users


How to cite this article:
Thomson SR, Chogtu B, Shetty R, Devasia T. Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study.Indian J Pharmacol 2018;50:320-325


How to cite this URL:
Thomson SR, Chogtu B, Shetty R, Devasia T. Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study. Indian J Pharmacol [serial online] 2018 [cited 2023 Mar 23 ];50:320-325
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2018;volume=50;issue=6;spage=320;epage=325;aulast=Thomson;type=0